Your browser doesn't support javascript.
loading
Phase 2 study of afatinib among patients with recurrent and/or metastatic esophageal squamous cell carcinoma.
Hong, Min Hee; Heo, Seong Gu; Lee, Yun-Gyoo; Kim, Hyo Song; Park, Keon Uk; Kim, Hoon-Gu; Ko, Yoon Ho; Chung, Ik-Joo; Min, Young Joo; Kim, Min Kyoung; Kim, Kyu Ryung; Yoo, Jinseon; Kim, Tae-Min; Kim, Hye Ryun; Cho, Byoung Chul.
Afiliación
  • Hong MH; Division of Medical Oncology, Department of Internal Medicine, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Korea.
  • Heo SG; JE-UK Institute for Cancer Research, JEUK Company Ltd, Gumi-City, Kyungbuk, Korea.
  • Lee YG; Department of Internal Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Korea.
  • Kim HS; Division of Medical Oncology, Department of Internal Medicine, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Korea.
  • Park KU; Division of Hematology/Oncology, Department of Internal Medicine, Keimyung University Dongsan Medical Center, Daegu, Korea.
  • Kim HG; Department of Internal Medicine, Institute of Health Sciences, Gyeongsang National University Hospital, Gyeongsang National University School of Medicine, Jinju, Korea.
  • Ko YH; Division of Oncology, Department of Internal Medicine, Uijeongbu St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.
  • Chung IJ; Department of Hemato-Oncology, Chonnam National University Hwasun Hospital, Hwasun, Korea.
  • Min YJ; Department of Hematology and Oncology, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, Korea.
  • Kim MK; Department of Internal Medicine, Yeungnam University Medical Center, Daegu, Korea.
  • Kim KR; Department of Medical Informatics, College of Medicine, The Catholic University of Korea, Seoul, Korea.
  • Yoo J; Cancer Research Institute, College of Medicine, The Catholic University of Korea, Seoul, Korea.
  • Kim TM; Department of Medical Informatics, College of Medicine, The Catholic University of Korea, Seoul, Korea.
  • Kim HR; Cancer Research Institute, College of Medicine, The Catholic University of Korea, Seoul, Korea.
  • Cho BC; Department of Medical Informatics, College of Medicine, The Catholic University of Korea, Seoul, Korea.
Cancer ; 126(20): 4521-4531, 2020 10 15.
Article en En | MEDLINE | ID: mdl-32749686
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Carcinoma de Células Escamosas de Esófago / Afatinib Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Cancer Año: 2020 Tipo del documento: Article Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Carcinoma de Células Escamosas de Esófago / Afatinib Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Cancer Año: 2020 Tipo del documento: Article Pais de publicación: Estados Unidos